Continuous activation of PpIX by daylight is as effective as and less painful than conventional photodynamic therapy for actinic keratoses; a randomized, controlled, single-blinded study
- 1 April 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 158 (4), 740-746
- https://doi.org/10.1111/j.1365-2133.2008.08450.x
Abstract
Photodynamic therapy (PDT) is a highly effective treatment for actinic keratoses (AK); however, it is time consuming and often painful for the patient. Daylight-PDT would make the treatment independent of the clinic and less painful due to the continuous activation of small amounts of porphyrins during its formation. The objective of this randomized controlled study was to compare response rates and adverse effects after methyl aminolevulinate (MAL)-PDT using conventional red light-emitting diode (LED) light vs. daylight. Twenty-nine patients with AK of the face and scalp were treated with MAL-PDT in two symmetrical areas. One area was illuminated by red LED light (37 J cm(-2)) after 3-h incubation with MAL under occlusive dressing. The other area was treated with daylight for 2.5 h after the MAL cream had been under occlusion for half an hour. We found no significant difference in the treatment effect between the two treatments (P = 0.13), with a reduction of AK lesions of 79% in the daylight area compared with 71% in the LED area. Treatment response in the daylight area did not depend on the intensity of the daylight. Illumination with LED was more painful than daylight (P < 0.0001). Erythema and crusting occurred after both treatments and were similar in the two areas. PDT of AK by continuous activation of porphyrins by daylight proved to be as effective as conventional PDT. PDT using daylight activation will make the treatment of these extremely common premalignant tumours more time and cost effective, and more convenient for the patient.Keywords
This publication has 16 references indexed in Scilit:
- AL amyloidosis enhances development of amyloid A amyloidosisBritish Journal of Dermatology, 2007
- Intraindividual, right-left comparison of topical methyl aminolaevulinate-photodynamic therapy and cryotherapy in subjects with actinic keratoses: a multicentre, randomized controlled studyBritish Journal of Dermatology, 2006
- Porphyrin Formation in Actinic Keratosis and Basal Cell Carcinoma after Topical Application of Methyl 5-AminolevulinateJournal of Investigative Dermatology, 2006
- Randomized, double-blind, placebo-controlled prospective study of the efficacy of topical anaesthesia with a eutetic mixture of lignocaine 2·5% and prilocaine 2·5% for topical 5-aminolaevulinic acid-photodynamic therapy for extensive scalp actinic keratosBritish Journal of Dermatology, 2005
- Light distribution and calibration of commercial PDT LED arraysPublished by Springer Science and Business Media LLC ,2005
- A Randomized Multicenter Study to Compare Two Treatment Regimens of Topical Methyl Aminolevulinate (Metvix ® )‐PDT in Actinic Keratosis of the Face and ScalpPublished by Medical Journals Sweden AB ,2005
- A randomized, double-blind, placebo-controlled study of the efficacy of tetracaine gel (AmetopR) for pain relief during topical photodynamic therapyBritish Journal of Dermatology, 2004
- A Trial of Short Incubation, Broad-Area Photodynamic Therapy for Facial Actinic Keratoses and Diffuse PhotodamageArchives of Dermatology, 2004
- Preferential Relative Porphyrin Enrichment in Solar Keratoses upon Topical Application of ^‐Aminolevulinic Acid MethylesterPhotochemistry and Photobiology, 1998
- A double-blind, vehicle-controlled study evaluating masoprocol cream in the treatment of actinic keratoses on the head and neckJournal of the American Academy of Dermatology, 1991